CNS cancer immunity cycle and strategies to target this for glioblastoma

Malaka Ameratunga1, Niamh Coleman1, Liam Welsh2

  • 1Drug Development Unit, Royal Marsden Hospital and The Institute of Cancer Research, Sutton SM2 5PT, UK.

Oncotarget
|June 2, 2018
PubMed

Insights

Immunotherapeutics show promise for solid tumors but face challenges in brain cancers like glioblastoma. This review explores why immunotherapies struggle in the central nervous system (CNS) and how to overcome these hurdles.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cancer Research

Background:

  • Immunotherapeutics have transformed solid tumor treatment.
  • Checkpoint inhibitors have shown limited efficacy in central nervous system (CNS) malignancies.
  • Glioblastoma presents unique challenges for immunotherapy.

Purpose of the Study:

  • To review the challenges hindering immunotherapy success in CNS tumors.
  • To utilize the cancer-immunity cycle as a framework for understanding these challenges.
  • To identify potential strategies for improving immunotherapy in brain cancers.

Main Methods:

  • Literature review utilizing the cancer-immunity cycle as a conceptual framework.
  • Analysis of factors affecting immunotherapy in the CNS environment.
  • Discussion of blood-brain barrier (BBB) implications for drug delivery and lymphocyte trafficking.

Main Results:

  • The CNS immune microenvironment, particularly in glioblastoma, poses significant barriers.
  • The blood-brain barrier (BBB) restricts effective drug delivery and immune cell infiltration.
  • Current immunotherapeutic strategies face limitations in penetrating and functioning within the CNS.

Conclusions:

  • Overcoming CNS-specific barriers is crucial for advancing brain cancer immunotherapy.
  • Targeting the tumor microenvironment and enhancing drug delivery are key strategies.
  • The cancer-immunity cycle provides a valuable lens for developing future CNS immunotherapeutics.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
What is the Immune System?01:38

What is the Immune System?

Overview
131.2K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
84.1K
What are Biogeochemical Cycles?00:54

What are Biogeochemical Cycles?

The most common elements in organic molecules, carbon, hydrogen, oxygen, nitrogen, sulfur, and phosphorus, are only available in the ecosystem in limited amounts. Therefore, these nutrients must be recycled through both biotic and abiotic components of the ecosystem, in processes generally called biogeochemical cycles.
39.6K
The Water Cycle01:00

The Water Cycle

The Earth’s hydrosphere includes all of the areas where the storage and movement of water occurs. Since water is the basis of all living processes, the cycling of water is extremely important to ecosystem dynamics.
28.8K
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.3K